Essential Thrombocythemia








Overview


What Is Essential Thrombocythemia (ET)?

Essential thrombocythemia is a chronic condition where patients' bone marrow makes too many platelets. The excess platelets increase the risk of blood clots which can lead to strokes and heart attacks. The disease most commonly affects people over age 50, but also affects children in rare cases.



Diagnosis


Diagnosing Essential Thrombocythemia (ET)

There is no definitive test for essential thrombocythemia. Instead it is diagnosed by doctor experienced in eliminating other possible causes of the signs and symptoms of the disease. 


Treatments


What Is Essential Thrombocythemia (ET)?

• A personalized, team approach

Patients with essential thrombocythemia are evaluated and treated in Hematology department by a team of world-renowned doctors. We offer state-of-the-art chemotherapy protocols for leukemia. Our goal is to improve the survival and quality of life of patients.

(The content above extract from stanfordhealthcare.org)












Stay in Touch
©2017 Lu Daopei hospital-22 Tongji South Rd, Yizhuang Ecomonic and Technological Development Zone, Daxing District, Beijing, China. All rights reserved.
冀ICP备18002416号-1